Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Effectiveness of Siponimod with Up to 2 Years of Treatment in a Real-World Setting in People with SPMS: Analysis from the Novartis Global Managed Access Program
Saved in:
| Published in: | Degenerative Neurological and Neuromuscular Disease |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867301676034031619 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Degenerative Neurological and Neuromuscular Disease |
| description | |
| discipline_display | Psychiatry and Neurology |
| discipline_facet | Psychiatry and Neurology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:59032 |
| institution | FRELIP |
| journal_source_facet | Degenerative Neurological and Neuromuscular Disease |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Effectiveness of Siponimod with Up to 2 Years of Treatment in a Real-World Setting in People with SPMS: Analysis from the Novartis Global Managed Access Program Psychiatry and Neurology General Psychiatry and Neurology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Psychiatry and Neurology General Psychiatry and Neurology Psychiatry and Neurology General Psychiatry and Neurology |
| subject_facet | Psychiatry and Neurology General Psychiatry and Neurology |
| title | Effectiveness of Siponimod with Up to 2 Years of Treatment in a Real-World Setting in People with SPMS: Analysis from the Novartis Global Managed Access Program |
| title_auth | Effectiveness of Siponimod with Up to 2 Years of Treatment in a Real-World Setting in People with SPMS: Analysis from the Novartis Global Managed Access Program |
| title_full | Effectiveness of Siponimod with Up to 2 Years of Treatment in a Real-World Setting in People with SPMS: Analysis from the Novartis Global Managed Access Program |
| title_fullStr | Effectiveness of Siponimod with Up to 2 Years of Treatment in a Real-World Setting in People with SPMS: Analysis from the Novartis Global Managed Access Program |
| title_full_unstemmed | Effectiveness of Siponimod with Up to 2 Years of Treatment in a Real-World Setting in People with SPMS: Analysis from the Novartis Global Managed Access Program |
| title_short | Effectiveness of Siponimod with Up to 2 Years of Treatment in a Real-World Setting in People with SPMS: Analysis from the Novartis Global Managed Access Program |
| title_sort | effectiveness of siponimod with up to 2 years of treatment in a real-world setting in people with spms: analysis from the novartis global managed access program |
| topic | Psychiatry and Neurology General Psychiatry and Neurology |
| url | https://www.dovepress.com/effectiveness-of-siponimod-with-up-to-2-years-of-treatment-in-a-real-w-peer-reviewed-fulltext-article-DNND |